|
Platelet function inhibitors
Citations 21-30 of 251 total displayed.
|
Past content
(since Oct 2000):
|
- Articles
Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel. Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes
- Jessica L. Mega, Sandra L. Close, Stephen D. Wiviott, Lei Shen, Richard D. Hockett, John T. Brandt, Joseph R. Walker, Elliott M. Antman, William L. Macias, Eugene Braunwald, and Marc S. Sabatine
Circulation published May 4, 2009, doi:10.1161/CIRCULATIONAHA.109.851949
[Abstract]
- Editorials
Stopping the Hemorrhage: A New Baseline Bleeding Score Brings Us a Step Closer for Patients With Non–ST-Elevation Myocardial Infarction
- Jeffrey L. Anderson
Circulation 2009;119:1846-1849, doi:10.1161/CIRCULATIONAHA.109.854281
[Full text]
- Interventional Cardiology
Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading: A Randomized Double-Blind Trial
- Julinda Mehilli, Adnan Kastrati, Stefanie Schulz, Stefan Früngel, Stephan G. Nekolla, Werner Moshage, Franz Dotzer, Kurt Huber, Jürgen Pache, Josef Dirschinger, Melchior Seyfarth, Stefan Martinoff, Markus Schwaiger, Albert Schömig for the Bavarian Reperfusion Alternatives Evaluation-3 (BRAVE-3) Study Investigators
Circulation 2009;119:1933-1940; published online before print as doi:10.1161/CIRCULATIONAHA.108.818617
[Abstract]
[Full text]
- Editorials
Antithrombotic Therapy in Heart Failure: WATCHful Wondering
- Marvin A. Konstam
Circulation 2009;119:1559-1561, doi:10.1161/CIRCULATIONAHA.109.850198
[Full text]
- Articles
Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading. A Randomized Double-Blind Trial
- Julinda Mehilli, Adnan Kastrati, Stefanie Schulz, Stefan Früngel, Stephan G. Nekolla, Werner Moshage, Franz Dotzer, Kurt Huber, Jürgen Pache, Josef Dirschinger, Melchior Seyfarth, Stefan Martinoff, Markus Schwaiger, Albert Schömig for the Bavarian Reperfusion Alternatives Evaluation-3 (BRAVE-3) Study Investigators
Circulation published March 30, 2009, doi:10.1161/CIRCULATIONAHA.108.818617
[Abstract]
- Statistical Primer for Cardiovascular Research
Optimizing Trial Design: Sequential, Adaptive, and Enrichment Strategies
- Cyrus Mehta, Ping Gao, Deepak L. Bhatt, Robert A. Harrington, Simona Skerjanec, and James H. Ware
Circulation 2009;119:597-605, doi:10.1161/CIRCULATIONAHA.108.809707
[Full text]
- Health Services and Outcomes Research
Antiplatelet Therapy Use After Discharge Among Acute Myocardial Infarction Patients With In-Hospital Bleeding
- Tracy Y. Wang, Lan Xiao, Karen P. Alexander, Sunil V. Rao, Mikhail N. Kosiborod, John S. Rumsfeld, John A. Spertus, and Eric D. Peterson
Circulation 2008;118:2139-2145; published online before print as doi:10.1161/CIRCULATIONAHA.108.787143
[Abstract]
[Full text]
- Articles
Antiplatelet Therapy Use After Discharge Among Acute Myocardial Infarction Patients With In-Hospital Bleeding
- Tracy Y. Wang, Lan Xiao, Karen P. Alexander, Sunil V. Rao, Mikhail N. Kosiborod, John S. Rumsfeld, John A. Spertus, and Eric D. Peterson
Circulation published November 3, 2008, doi:10.1161/CIRCULATIONAHA.108.787143
[Abstract]
- Interventional Cardiology
Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Systematic Review
- Pieter J. Vlaar, Tone Svilaas, Kevin Damman, Bart J.G.L. de Smet, Jan G.P. Tijssen, Hans L. Hillege, and Felix Zijlstra
Circulation 2008;118:1828-1836; published online before print as doi:10.1161/CIRCULATIONAHA.107.749531
[Abstract]
[Full text]
- Coronary Heart Disease
Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid: Determinants and Effect on Cardiovascular Risk
- John W. Eikelboom, Graeme J. Hankey, Jim Thom, Deepak L. Bhatt, P. Gabriel Steg, Gilles Montalescot, S. Claiborne Johnston, Steven R. Steinhubl, Koon-Hou Mak, J. Donald Easton, Christian Hamm, Tingfei Hu, Keith A.A. Fox, Eric J. Topol on behalf of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) Investigators
Circulation 2008;118:1705-1712; published online before print as doi:10.1161/CIRCULATIONAHA.108.768283
[Abstract]
[Full text]
|
|
